|
Reference | Study design | Location | Year of study | Number of patients | Rate of infection |
|
Lossa et al. 2008 [16] | Cross-sectional, multicenter | Argentina nationwide | 2004 and 2005 | 356 | (i) Pooled prevalence, 24% (95% CI, 20%–29%) (a) Pneumonia, 43% (b) BSI, 21% (c) UTI, 13% |
|
Luna et al. 2003 [17] | Prospective, multicenter | Buenos Aires, Argentina | 1999–2001 | 472 | (i) VAP incidence, 63/472 (13%) |
|
Toufen Junior et al. 2003 [18] | 1-day point prevalence | São Paulo, Brazil | 2000 | 126 | (i) Overall prevalence, 72/126 (57%) (a) CAI, 15/72 (21%) (b) Non-ICU nosocomial infection, 24/72 (33%) (c) ICU-acquired infection, 22/72 (31%) (d) Undefined, 11/72 (15%) |
|
de Queiroz Guimarães and Rocco 2006 [19] | Prospective observational | Rio de Janeiro, Brazil | 1999–2001 | 278 | (i) VAP prevalence, 38% (36 cases/1000 ventilator days) |
|
Lima et al. 2007 [20] | Prospective observational | São Paulo, Brazil | 2006 | 71 | (i) Prevalence, 47/71 (66%) |
|
da Rocha et al. 2008 [21] | Prospective observational | Uberlândia, Brazil | 2005-2006 | 275 | (i) VAP prevalence, 31% (25 cases/1000 ventilator days) |
|
Rodrigues et al. 2009 [22] | Prospective observational | Rio de Janeiro, Brazil | 2005–2007 | 233 | (i) VAP prevalence, 27% (17 cases/1000 ventilator days) |
|
de Oliveira et al. 2010 [23] | Prospective observational | Minas Gerais, Brazil | 2005–2008 | 2300 | (i) CAI, 437/2300 (19%) (a) 284 (12%) patients colonized by resistant microorganisms during ICU hospitalization, 61% of whom developed an infection (ii) Nosocomial infection, 311/2300 (14%) (a) 84/311 (27%) owing to resistant pathogens |
|